DXCM· Biotech / Healthcare

DexCom, Inc.

PER 32.3ROE 35.6%

Fundamentals

P/E Ratio32.3
P/B Ratio9.82
ROE35.6%
Operating Margin21.4%
Revenue Growth15.0%
EPS2.33
Dividend Yield—
Debt Ratio46.8%
Free Cash Flow$1.06B
Market Cap$29.04B

Source: Yahoo Finance · Synced daily · Dividend yield expressed as decimal percent.

Sector Position

neutral
Biotech / HealthcareScore 584 stocks in universe

Peers in sector

INCYIncyte Corporation
PER 14.5ROE 30.8%
CIThe Cigna Group
PER 2.6ROE 16.3%
069620.KSDaewoong Pharmaceutical Co., Ltd
PER 6.5ROE 19.1%
AMGNAmgen Inc.
PER 24.3ROE 101.3%
BMYBristol-Myers Squibb Company
PER 16ROE 38.7%

AI Insight

DexCom, Inc. shows strong ROE 35.6%, PER 32.3, high operating margin 21.4%, revenue growth 15.0% based on the latest fundamentals snapshot.